semaglutide and anorexia GLP-1 medications are changing the conversation around weight health, but what about eating disorder risk? Join us for our 30-minute May Micro Learning Session: The GLP-1 Era: Navigating Weight Loss Drugs Ozempic is everywhere and that's

Clinical safety and tolerability of vildagliptin - insights from randomised trials, observational studies and post-marketing surveillance

Tastes good hot, warm or cold

AI panel on Insights+ reports The Mployer AI panel on Insights+ HTML reports has been redesigned to match the AI panels in the rest of the platform, with the same layout, controls, and prompt patterns

Nevertheless, GLP-1 RAs have gastrointestinal adverse effects such as abdominal pain, constipation, diarrhea, nausea, and vomiting [7]

Laboratory findings help explain why scientists remain interested, but they cannot establish clinical benefit by themselves